Activation of channel activity of the NMDA receptor-PSD-95 complex by guanylate kinase-associated protein (GKAP)  by Yamada, Yasue et al.
Activation of channel activity of the NMDA receptor-PSD-95 complex
by guanylate kinase-associated protein (GKAP)
Yasue Yamadaa, Yasuyo Chochia, Ji-Ae Koa, Kenji Sobueb, Makoto Inuia;*
aDepartment of Pharmacology, Yamaguchi University School of Medicine, Minamikogushi 1-1-1, Ube, Yamaguchi 755-8505, Japan
bDepartment of Neurochemistry and Neuropharmacology, Osaka University Medical School, Yamadaoka 2-2, Suita, Osaka 565-0871, Japan
Received 14 June 1999; received in revised form 9 August 1999
Abstract The channel-associated protein PSD-95 functionally
modulates NMDA receptor channels, interacting with the
channels via PDZ domain of PSD-95. PSD-95 also interacts
with guanylate kinase-associated protein (GKAP) through the
guanylate kinase-like domain of PSD-95. Here we report that
GKAP markedly potentiates the channel activity of the receptor-
PSD-95 complex. However, GKAP had no effect on basic
properties of the channels nor on PSD-95-induced changes in
channel properties. Thus, GKAP affects the channel activity of
the NMDA receptor via PSD-95 quantitatively, which may make
signal transmission more efficient at postsynaptic sites.
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1. Introduction
The N-methyl-D-aspartate (NMDA) receptor is a subclass
of ionotropic glutamate receptors in the mammalian brain,
and exists as heteromultimers of the j1 subunit (NR1) with
O subunits (NR2s) [1,2]. Di¡erent combinations of these sub-
units exhibit distinct channel properties and characteristic re-
gional and developmental expression in vivo [3^5]. The acti-
vation of NMDA receptors is essential for induction of
synaptic long-term potentiation (LTP) which underlies the
formation and storage of some forms of memory [6].
The O subunits of the NMDA receptor have been shown to
interact with PSD-95 [7,8]. PSD-95 and its family proteins are
localized at postsynaptic density in neuronal cells, and are
characterized by the presence of three PDZ domains in the
NH2-terminal region, followed by SH3 and guanylate kinase-
like (GK) domains [9^15]. The ¢rst and second PDZ domains
interact with the COOH-terminal E-T/S-X-V sequence motif
of NMDA receptor O subunits [7,8] and of K channels
[16,17]. The interaction of these proteins induces the clustering
of the channel proteins [14,16,18]. A protein interacting with
the GK domain of PSD-95 has been identi¢ed by the yeast
two-hybrid method, and named GKAP (guanylate kinase-as-
sociated protein) or SAPAP (SAP90/PSD-95-associated pro-
tein) [19^21]. GKAP co-localizes with PSD-95 in hippocampal
neurons [20,22], and forms a complex with the NMDA recep-
tor and PSD-95 [19,20].
Recently, we found that PSD-95 functionally modulates the
O2/j1 heteromeric NMDA receptor channels; it decreases the
a⁄nity of the channels to L-glutamate and inhibits the protein
kinase C-mediated potentiation of the channels [23]. In this
study, we examined whether the channel activity of the recep-
tor-PSD-95 complex is further modulated by GKAP, and
found that GKAP signi¢cantly potentiates the channel activ-
ity of the NMDA receptor through PSD-95.
2. Materials and methods
2.1. Preparation of cRNA and oocytes
Complementary RNAs of NMDA receptors and PSD-95 were syn-
thesized as described previously [23]. Deletion mutants of PSD-95
were prepared as described previously [23]. The cDNA fragment of
GKAP (nucleotide positions 19^2343, GenBank U67987) was sub-
cloned into pBKSA [24]. Complementary RNA of GKAP was syn-
thesized in vitro with T3 RNA polymerase using the NotI-cleaved
plasmid as a template.
Stage V and VI oocytes were obtained from Xenopus laevis as de-
scribed previously [23]. The oocytes were injected with O2 and j1
cRNAs in a molar ratio of 1:2 (O2:j1). The total amounts of
cRNA injected were 5 ng per oocyte. For co-expression of PSD-95,
the synthesized PSD-95 cRNA (12.5 ng) was injected 24 h after the
injection of the NMDA receptor cRNAs. For co-expression of PSD-
95 and GKAP, cRNAs of PSD-95 (12.5 ng) and GKAP (12.5^25 ng)
were co-injected. Before recording, oocytes were incubated at 19‡C for
18^26 h in Barth’s medium (88 mM NaCl, 1 mM KCl, 0.33 mM
Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 2.4 mM NaHCO3,
and 7.7 mM Tris-HCl, pH 7.2).
2.2. Electrophysiological recordings
Currents were recorded with two-electrode voltage-clamp tech-
niques using a CA-1a high performance oocyte clamp (Dagan
Corp., Minneapolis, MN, USA). Electrodes were ¢lled with 3 M
KCl and had resistances of 1^5 M6. Oocytes were perfused by a
constant stream of Ba2 Ringer solution (115 mM NaCl, 2.5 mM
KCl, 1.8 mM BaCl2, and 10 mM HEPES, pH 7.2) at 23^25‡C. The
oocyte membrane was voltage-clamped at 370 mV. In the standard
assay, currents were evoked by bath perfusion of Ba2 Ringer solu-
tion containing 100 WM L-glutamate and 10 WM glycine for 20 s,
followed by a washout with standard Ba2 Ringer solution. Current
signals were digitized for analysis, statistical signi¢cance was deter-
mined by ANOVA followed by Dunnett’s multiple comparison test.
P6 0.05 was considered to be statistically signi¢cant.
2.3. Immunoblotting
Polyclonal antibodies against O2 and j1 subunits of NMDA recep-
tor were obtained from Calbiochem (La Jolla, CA, USA) and Santa
Cruz Biotechnology (Santa Cruz, CA, USA), respectively. After meas-
urement of current responses, oocytes were combined and homogen-
ized with 100 mM NaCl, 5 mM EDTA, 20 mM Tris-HCl, pH 7.5, and
then centrifuged at 1000Ug for 10 min. The supernatant was centri-
fuged at 200 000Ug for 30 min. The obtained pellet (total membrane
fraction) was solubilized with Laemmli gel sample bu¡er. The samples
were separated by SDS-polyacrylamide gel electrophoresis on a 5%
gel, and transferred to a nitrocellulose sheet. After blocking with 5%
skim milk and 0.05% Tween 20 in Tris-HCl-bu¡ered saline, the sheets
were incubated with primary antibodies in block solution. Labeled
bands were visualized using enhanced chemiluminescence (Pierce,
Rockford, IL, USA). The bands were analyzed by densitometric scan-
ning using Densitograph AE-6900M (Atto, Tokyo, Japan). The
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amounts of the proteins were quanti¢ed from the intensity of the
bands, which has a linearity to the amounts of the samples applied
to the gel.
3. Results and discussion
3.1. Co-expression of NMDA receptor channels, PSD-95 and
GKAP
To investigate the e¡ects of GKAP (or SAPAP1) on the O2/
j1 heteromeric NMDA receptor-PSD-95 complex, we ex-
pressed the NMDA receptor, PSD-95 and GKAP in Xenopus
oocytes by injection of in vitro synthesized cRNAs, and meas-
ured current responses to 100 WM L-glutamate and 10 WM
glycine in Ba2 Ringer solution, comparing them with those
in oocytes expressing the receptor and co-expressing PSD-95.
Typical traces of the current responses are shown in Fig. 1.
The average of the current responses from about 50 oocytes
was 2-fold increased by expression of PSD-95, and was 5-fold
increased by co-expression of PSD-95 and GKAP (Table 1).
Since co-expression of PSD-95 and/or GKAP may change the
expression level of the receptor, we compared the amounts of
the receptor expressed in these oocytes by immunoblotting. In
accord with our previous results [23], PSD-95 caused a 2-fold
increase in the expression of the receptor, so that the channel
activity normalized by the expression level of the receptor was
almost the same as that in oocytes expressing the receptor
alone (Table 1). On the other hand, co-expression of PSD-
95 and GKAP caused a 1.7-fold increase in the expression of
the receptor (Table 1). The normalized channel activity was
about 3-fold increased in these oocytes (Table 1). This poten-
tiation is not due to a direct e¡ect of GKAP on the receptor,
because no di¡erence in the channel activity was observed
between oocytes expressing the receptor alone and co-express-
ing GKAP without PSD-95 (Fig. 2) and because the potentia-
tion of the channel activity was not observed in oocytes co-
expressing the receptor, GKAP and the deletion mutant of
PSD-95 which lacks GK domain (Fig. 2). The expression level
of PSD-95 was not changed by co-expression of GKAP, when
examined by the immunoblotting with anti-PSD-95 antibodies
(data not shown). The immunoblotting also revealed that the
ratio between O2 and j1 subunits was not changed among
three groups of oocytes (Table 1), indicating that the PSD-
95-GKAP complex does not inhibit plasma membrane inser-
tion of the O2 subunit.
3.2. E¡ects of GKAP on the channel properties of the NMDA
receptor-PSD-95 complex
Recently, we reported that PSD-95 has two inhibitory ef-
fects on the O2/j1 NMDA receptor; PSD-95 decreases the
sensitivity of the channels to L-glutamate, and inhibits the
protein kinase C-mediated potentiation of the channels [23].
We next examined whether GKAP changes these channel
properties of the receptor interacting with PSD-95. As we
reported previously [23], PSD-95 decreased the sensitivity of
the NMDA receptor channels to L-glutamate, shifting the
dose-response curve to the right (Fig. 3). GKAP did not
change the lower sensitivity of the channels to L-glutamate,
which was caused by PSD-95 (Fig. 3). The channel activity of
the O2/j1 NMDA receptor is markedly potentiated by treat-
ment with 12-O-tetradecanoylphorbol 13-acetate (TPA) [25^
27]. PSD-95 inhibits the potentiation of the channels induced
by TPA (Fig. 4) [23]. The potentiation by TPA was not ob-
served in oocytes co-expressing PSD-95 and GKAP (Fig. 4).
The latter observation indicates that the binding of GKAP to
PSD-95 does not a¡ect the inhibition of protein kinase C-
mediated channel potentiation, which is caused by PSD-95.
However, the possibility cannot be ruled out that the interac-
tion between PSD-95 and GKAP is disrupted by protein kin-
ase C-catalyzed phosphorylation. There was no di¡erence in
the glycine sensitivity, the current-voltage relationship and a
voltage-dependent Mg2 block of the channels among three
groups of oocytes expressing the receptor alone, co-expressing
PSD-95, and co-expressing PSD-95 and GKAP (data not
Fig. 1. Current responses to L-glutamate in oocytes co-expressing
the O2/j1 heteromeric NMDA receptor, PSD-95 and GKAP. Oo-
cytes were injected with in vitro synthesized cRNAs of the NMDA
receptor (A), of the receptor and PSD-95 (B), or of the receptor,
PSD-95 and GKAP (C). Current responses were measured in Mg2-
free Ba2 Ringer solution at 370 mV membrane potential as de-
scribed in Section 2. Bars show the duration of application of
100 WM L-glutamate with 10 WM glycine. Inward current is down-
ward.
Table 1
Channel activity and amounts of expressed NMDA receptor subunits
Oocyte Current response
(WA)
Amounts of O2
(arbitrary units)
Amounts of j1
(arbitrary units)
O2/j1 Normalized channel activity
(current response/O2)
(WA/arbitrary unit)
O2/j1 0.345 þ 0.025 (55) 0.735 1.570 0.468 0.469
O2/j1+PSD-95 0.757 þ 0.043* (57) 1.414 2.826 0.500 0.535
O2/j1+PSD-95+GKAP 1.812 þ 0.118*2 1.235 2.539 0.486 1.467
Current responses evoked by 100 WM L-glutamate and 10 WM glycine were measured in the number of oocytes indicated in parentheses, and
are presented as mean þ S.E.M. After measurement of current responses, oocytes of each group were combined and the total membrane fraction
was prepared. The samples were separated by SDS-polyacrylamide gel electrophoresis on a 5% gel, and immunoblotting was performed with
anti-j1 subunit and anti-O2 subunit antibodies as described in Section 2.
*P6 0.001 compared with oocytes expressing the NMDA receptor (O2/j1) alone; 2P6 0.001 compared with oocytes expressing the NMDA
receptor and PSD-95.
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shown). Thus, GKAP does not change the channel properties
of the NMDA receptor-PSD-95 complex, although it mark-
edly potentiates the channel activity of the receptor in the
presence of PSD-95.
3.3. Possible roles of GKAP in modulation of NMDA receptor
channels
We demonstrated that GKAP potentiates the channel ac-
tivity of the NMDA receptor via PSD-95, while it does not
a¡ect the inhibitory e¡ects of PSD-95 on the channels. What
is the functional signi¢cance of these two modes of the chan-
nel modulation? The inhibitory e¡ects of PSD-95 on the
NMDA receptor channels might be related to induction of
LTP. It is known that protein kinase C is necessary for in-
duction of LTP [6]. PSD-95 may elevate the threshold of LTP
induction, inhibiting the protein kinase C-mediated potentia-
tion of the NMDA receptor channels. It was reported that
LTP is enhanced in mutant mice lacking PSD-95 [28]. Based
on neural network models incorporating bidirectional synap-
tic plasticity (potentiation and depression), the enhanced LTP
which can be induced by low-frequency stimulation is accom-
panied by severely impaired learning and memory. In those
mutant mice, in fact, spatial learning was impaired [28]. On
the other hand, GKAP increases the channel activity. Since
GKAP did not alter the basic channel properties nor a PSD-
95-induced change in channel properties, GKAP may increase
the number of functional channels, which is probably related
to clustering of the channels. It is known that PSD-95 can
induce the channel clustering without GKAP [14,16,18].
GKAP may strengthen the cluster sca¡old. Thus, GKAP af-
fects the channel activity of the NMDA receptor via PSD-95
quantitatively, which may make signal transmission more ef-
Fig. 2. Current responses to L-glutamate in oocytes expressing the
NMDA receptor with GKAP and/or deletion mutant of PSD-95.
Oocytes were injected with various combinations of cRNAs of the
NMDA receptor, PSD-95 or deletion mutant of PSD-95 (vPSD-95),
and GKAP. Current responses to 100 WM L-glutamate with 10 WM
glycine were measured. The deletion mutant which lacks SH3 and
GK domains had the same e¡ects on the NMDA receptor channels
as the wild-type PSD-95, as reported previously [23]. However, the
potentiation of current responses by GKAP was not observed with
this mutant. The data shown are the mean þ S.E.M. of the number
of oocytes indicated in parentheses. *P6 0.01.
Fig. 3. Dose-response curves for L-glutamate in oocytes co-express-
ing the O2/j1 NMDA receptor, PSD-95 and GKAP. Various con-
centrations of L-glutamate with 10 WM glycine were applied, and
the steady-state currents were measured in oocytes injected with the
NMDA receptor cRNAs (closed circles), with the receptor and
PSD-95 cRNAs (open circles), or with the receptor, PSD-95 and
GKAP cRNAs (closed triangles). Each point represents the mean þ
S.E.M. of the current amplitudes obtained from ¢ve oocytes. The
EC50 values were 1.81 WM, 5.62 WM and 4.67 WM for oocytes ex-
pressing the NMDA receptor, co-expressing PSD-95, and co-ex-
pressing PSD-95 and GKAP, respectively, and the Hill coe⁄cient
values were 1.53, 1.02 and 1.16, respectively.
Fig. 4. E¡ects of TPA on current responses in oocytes co-expressing
the O2/j1 NMDA receptor, PSD-95 and GKAP. Current responses
were measured in oocytes expressing the receptor, co-expressing
PSD-95, and co-expressing PSD-95 and GKAP before and after
bath application of 1 WM TPA for 10 min. The potentiation of cur-
rent response by TPA treatment is presented. The data shown are
the mean þ S.E.M. of the number of oocytes indicated in parenthe-
ses. The potentiation of current response by TPA was 5.43 þ 0.75,
1.41 þ 0.10, and 1.06 þ 0.10 in oocytes expressing the receptor, co-ex-
pressing PSD-95, and co-expressing PSD-95 and GKAP, respec-
tively. *P6 0.01 compared with oocytes expressing the receptor
alone. There was no statistical di¡erence in the potentiation between
oocytes co-expressing PSD-95, and co-expressing PSD-95 and
GKAP.
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¢cient at postsynaptic sites. Further studies are necessary to
elucidate the mechanism of the channel potentiation by
GKAP via PSD-95.
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